Named on one round in the feed.
Since ~ 2020-09-01
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Aqua Medical, Inc. A clinical-stage medical technology company advancing Endoscopic Metabolic Restoration for the treatment of Type 2 diabetes | Series A Published on thinner evidence, 1 source[ HISTORY ]: An earlier round of this company, found through its checked dossier and read from its own announcement like any round. Not news: never sent, and left out of the feed unless you filter by date. | $8.2M | ~ 2020-09-01 | [ PART ] |